Your browser doesn't support javascript.
loading
The Clinician's Tardive Inventory (CTI): A New Clinical Tool for Documenting and Rating Tardive Dyskinesia.
Trosch, Richard M; Comella, Cynthia L; Caroff, Stanley N; Ondo, William G; Shillington, Alicia C; LaChappelle, Brandon J; Hauser, Robert A; Correll, Christoph U; Friedman, Joseph H.
Affiliation
  • Trosch RM; Oakland University, William Beaumont Medical School, Rochester, Michigan.
  • Comella CL; Rush University, Chicago, Illinois.
  • Caroff SN; University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
  • Ondo WG; Houston Methodist Neurological Institute, Houston, Texas.
  • Shillington AC; Weill Cornell Medical School, New York, New York.
  • LaChappelle BJ; EPI-Q Inc, Oakbrook, Illinois.
  • Hauser RA; EPI-Q Inc, Oakbrook, Illinois.
  • Correll CU; University of South Florida, Tampa, Florida.
  • Friedman JH; The Zucker Hillside Hospital, Department of Psychiatry, Northwell Health, Glen Oaks, New York.
J Clin Psychiatry ; 85(1)2024 Jan 24.
Article in En | MEDLINE | ID: mdl-38270545
ABSTRACT

Objective:

Current clinician-rated tardive dyskinesia (TD) symptom scales have not addressed the expanding clinical signs and functional impact of TD. The study objective was to develop and test the reliability of a new integrated instrument.

Methods:

A movement disorder neurologist devised the outline of the rating scale. A Steering Committee (5 neurologists and 2 psychiatrists) provided revisions until consensus was reached. The Clinician's Tardive Inventory (CTI) assesses abnormal movements of the eye/eyelid/face, tongue/mouth, jaw, and limb/trunk; complex movements defined as complicated movements different from simple patterned movements or postures; and vocalizations. The CTI rates frequency of symptoms from 0 to 3 (ranging from absent to constant). Functional impairments, including activities of daily living (ADL), social impairment, symptom distress, and physical harm, are rated 0-3 (ranging from unawareness to severe impact). The CTI underwent interrater and test-retest reliability testing between February and June 2022 based on videos and accompanying vignettes, which were reviewed by 2 movement disorder specialists to determine adequacy. Four clinicians rated each video/vignette. Interrater agreement was analyzed via 2-way random-effects intraclass correlation (ICC), and test-retest agreement was assessed utilizing the Kendall tau-b.

Results:

Forty-five video/vignettes were assessed for interrater reliability and 16 for test-retest reliability. The most prevalent movements were those of the tongue and mouth (77.8%) and jaw (55.6%). ICCs for movement frequency for anatomic symptoms were as follows anatomic symptom summary score 0.92, abnormal eye movement 0.89, abnormal tongue/mouth movement 0.91, abnormal jaw movement 0.89, abnormal limb movement 0.76, complex movement 0.87, and abnormal vocalization 0.77; ICCs for functional impairments were as follows total impairment score 0.92, physical harm 0.82, social embarrassment 0.88, ADLs 0.83, and symptom bother 0.92; Retests were conducted a mean (SD) of 15 (3) days later with correlation coefficients ranging from 0.66 to 0.87.

Conclusions:

The CTI is a new integrated instrument with proven reliability in assessing TD signs and functional impacts. Future validation study is warranted.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tardive Dyskinesia / Movement Disorders Type of study: Diagnostic_studies / Guideline Limits: Humans Language: En Journal: J Clin Psychiatry Year: 2024 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tardive Dyskinesia / Movement Disorders Type of study: Diagnostic_studies / Guideline Limits: Humans Language: En Journal: J Clin Psychiatry Year: 2024 Document type: Article Country of publication: United States